April 20, 2020 by Chain Drug Review
COVID-19, Doug Hoey, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Nearly 90% of community pharmacies will apply for small business federal aid under the CARES Act to help them get through the coronavirus storm, according to a new survey released Monday by the National Community Pharmacists Association. “Pharmacies are ‘essential businesses’ staying open during the COVID-19 pandemic to keep serving their communities,
November 18, 2019 by Jeffrey Woldt
DIR fee reform, Doug Hoey, NCPA
November 18, 2019, Opinion
This space in the last issue of Chain Drug Review was devoted to the alarming results of a survey conducted by the National Community Pharmacists Association that show 58% of independent drug store owners think it is either somewhat or very likely that continued downward pressure on pharmacy reimbursements, particularly DIR fees, will force them
October 28, 2019 by Chain Drug Review
Cardinal Health, Doug Hoey, NCPA
Leading Headlines, Pharmacy
SAN DIEGO – The 2019 NCPA Digest, sponsored by Cardinal Health, was released today at the National Community Pharmacists Association’s Annual Convention here. The NCPA Digest, which provides an annual overview of independent community pharmacy, found that the industry in 2018 represented 35% of all retail pharmacies in the United States and a $75.8 billion
October 21, 2019 by Lari Harding
Doug Hoey, Inmar, Lari Harding
October 21, 2019, Opinion, Pharmacy
I had the opportunity to participate in a roundtable discussion — moderated by Chain Drug Review during the most recent NACDS Total Store Expo — that included leaders from across the industry representing chains, wholesalers, pharma and solution providers. It was a thoughtful and far-reaching exchange on a number of important topics, and we spent
August 23, 2018 by B. Douglas Hoey
Doug Hoey, National Community Pharmacists Association, pharmacy benefit managers
Issue 08-13-2018, Opinion
NEW YORK — Physicians Robin Warren and Barry Marshall were practically laughed out of health care in 1982 when they suggested that a type of bacteria might be causing stomach ulcers. It took more than a decade before their theory that treating ulcers with antibiotics to kill H. pylori bacteria was validated, and it radically